We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CCEP:LSECoca-Cola Europacific Partners plc Analysis

Data as of 2026-05-24 - not real-time

£6,960.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Coca‑Cola Europacific Partners is trading at 6,960 GBp, just above its 20‑day SMA (6,943 GBp) and comfortably above the 30‑day support of 6,643 GBp, while the 14‑day RSI sits at 49, indicating a neutral momentum environment. The MACD histogram is positive (≈+17) and the MACD line sits above the signal line, giving a bullish tilt despite the overall trend being labeled neutral. The stock offers a 2.61% dividend yield with a payout ratio of 48%, and recent news confirms a dividend increase and reaffirmed FY2026 guidance of 3‑4% revenue growth. Valuation metrics show a forward PE of 16.4 and a modest upside of about 5% versus the DCF‑derived fair value, suggesting the shares are at least fairly priced, if not slightly undervalued.
Fundamentally, the company delivers strong profitability (ROE ≈ 23%, operating margin ≈ 13.7%) and solid cash generation, but carries a high net‑debt load (debt‑to‑equity ≈ 130%). Volatility over the past 30 days is elevated at 21.8% yet beta is very low (≈0.15), reflecting limited systematic risk. The defensive consumer‑goods sector, stable dividend policy, and consistent earnings guidance combine to make CCEP a resilient holding for income‑focused investors while offering modest upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support but bullish MACD histogram
  • Stable volume and neutral RSI
  • Dividend increase reinforces income appeal

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Reaffirmed FY2026 revenue guidance and modest growth outlook
  • Strong ROE and operating cash flow supporting earnings sustainability
  • Fair valuation with ~5% upside and attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Defensive consumer‑goods positioning with global brand strength
  • Consistent dividend policy and payout ratio below 50%
  • Low systematic risk (beta ~0.15) and solid balance‑sheet cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth0.20%
Profit Margin9.29%
P/E Ratio18.9
ROE22.89%
ROA5.72%
Debt/Equity130.00
P/B Ratio4.6
Op. Cash Flow£3.0B
Free Cash Flow£1.7B

Technical Analysis

TrendNeutral
RSI49.2
Support£6,643.08
Resistance£7,435.00
MA 20£6,943.25
MA 50£7,090.80
MA 200£6,923.45
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value£2,963.53
Target Price£7,324.61
Upside/Downside5.24%
GradeFair
TypeBlend
Dividend Yield2.61%

Risk Assessment

Beta0.15
Volatility21.80%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.